Engineers Gate Manager »

Bioxcel Therapeutics shares owned by Engineers Gate Manager

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Engineers Gate Manager from 13F filings

Historical chart of Engineers Gate Manager investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Engineers Gate Manager consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Engineers Gate Manager

Quarter filed Position value Share count Share price at filing
2025-12-31 $20k 12k 1.60

More positions owned by Engineers Gate Manager

Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invitation Homes (INVH)
Sabra Health Care REIT (SBRA)
Agree Realty Corporation (ADC)
First Industrial Realty Trust (FR)
Phillips Edison & Co Common Stock (PECO)
Acadia Rlty Tr Com Sh Ben Int (AKR)
Itt (ITT)
Independence Realty Trust In (IRT)
SYSCO Corporation (SYY)
Procter & Gamble Company (PG)
Boston Scientific Corporation (BSX)
Equinix (EQIX)
Mccormick & Co Com Non Vtg (MKC)

View all positions for Engineers Gate Manager

Top funds holding Bioxcel Therapeutics

Millennium Management
Vanguard Group
Oaktree Capital Management
Geode Capital Management
FMR
Jones Financial Companies, L.L
Jane Street
GSA Capital Partners
BlackRock
State Street Corporation
Man Group
Oaktree Fund Advisors
HighTower Advisors
Northern Trust
UBS Group

View all funds holding Bioxcel Therapeutics